Login to Your Account



DIA 2015

Experts call for industry-wide collaboration in orphan drug development

By Richie Crider
Contributing Writer

Tuesday, June 16, 2015
WASHINGTON – Stakeholders from the health care, patient, academic and clinical industries gathered at the DIA 2015 annual meeting here to discuss, among other things, ways to improve orphan drug development to ensure patients with rare diseases receive timely, consistent, and effective treatment for their conditions.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription